XLRN
Acceleron Pharma Inc.
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
128 hedge funds and large institutions have $1.05B invested in Acceleron Pharma Inc. in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
-8
Holders Change %
-5.88%
% of All Funds
3.2%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
13
Increased
52
Reduced
32
Closed
21
Calls
$1.87M
Puts
$7.33M
Net Calls
-$5.46M
Net Calls Change
-$4.3M
Top Buyers
| 1 |
1
Westfield Capital Management
Boston,
Massachusetts
|
$51.1M |
| 2 |
SAM
2
Sectoral Asset Management
Montreal,
Quebec, Canada
|
$18.4M |
| 3 |
3
BlackRock
New York
|
$122M |
| 4 |
PC
4
Polar Capital
London,
United Kingdom
|
$32.7M |
| 5 |
5
Axa
Paris,
France
|
$9.83M |
